REFRACTORY B-CELL LYMPHOMA
Clinical trials for REFRACTORY B-CELL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY B-CELL LYMPHOMA trials appear
Sign up with your email to follow new studies for REFRACTORY B-CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Gene-Modified immune cells take on tough lymphoma
Disease control Recruiting nowThis study tests a new treatment called TranspoCART19 for people with B-cell lymphoma that has come back or not responded to standard therapy. The treatment uses a patient's own immune cells, which are genetically modified to better recognize and attack cancer cells. The trial wi…
Matched conditions: REFRACTORY B-CELL LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: Instituto de Investigación Biomédica de Salamanca • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New study tracks how CAR-T therapy impacts Seniors' daily lives
Knowledge-focused Recruiting nowThis study observes older patients (60+) receiving standard CAR-T therapy for blood cancers. Researchers track how treatment affects daily activities, thinking skills, and overall quality of life. No extra treatments are given—just careful monitoring to learn more about patient e…
Matched conditions: REFRACTORY B-CELL LYMPHOMA
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:04 UTC